glp-1 receptor agonist after roux-en-y gastric bypass Impact of Agonists in Gastrointestinal Endoscopy: An Updated Review GLP1-GIP receptor co-agonists: a promising

And when progress slows, patients look elsewhere

While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives

Glucagon-like peptide-1 (GLP-1) is a hormone involved in glucose homeostasis and satiety regulation

Case reports document perioperative aspiration in semaglutide users, including episodes of hypoxemia and reintubation despite guideline-concordant fasting

The most striking protective effects of SGLT2is were a marked reduction in hospitalization for heart failure and a remarkable reduced progression of chronic kidney disease

Glucagon-like peptide 1 or GLP-1 is a hormone produced in the gut and released in response to food